We are live on ! Find out more
BDSI

BioDelivery Sciences International, Inc.

Delisted

BDSI was delisted on the 22nd of March, 2022.

83 hedge funds and large institutions have $112M invested in BioDelivery Sciences International, Inc. in 2018 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 27 increasing their positions, 15 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,879% more call options, than puts

Call options by funds: $277K | Put options by funds: $14K

214% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 7

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

80% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 15

40% more capital invested

Capital invested by funds: $79.9M → $112M (+$31.6M)

22% more funds holding

Funds holding: 6883 (+15)

Holders
83
Holders Change
+15
Holders Change %
+22.06%
% of All Funds
1.9%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
22
Increased
27
Reduced
15
Closed
7
Calls
$277K
Puts
$14K
Net Calls
+$263K
Net Calls Change
+$95K
Name Holding Trade Value Shares
Change
Change in
Stake
TSS
51
Two Sigma Securities
New York
$104K +$104K +37,146 New
Janney Montgomery Scott
52
Janney Montgomery Scott
Pennsylvania
$102K -$7.61K -2,712 -7%
CCB
53
Cutter & Co Brokerage
Missouri
$99K
Barclays
54
Barclays
United Kingdom
$88K
VNA
55
Valley National Advisers
Pennsylvania
$64K -$42.1K -15,000 -40%
CAM
56
Close Asset Management
United Kingdom
$51K
UBS Group
57
UBS Group
Switzerland
$51K +$9.62K +3,426 +24%
Susquehanna International Group
58
Susquehanna International Group
Pennsylvania
$50K +$50.2K +17,880 New
Charles Schwab
59
Charles Schwab
California
$47K +$46.7K +16,652 New
Goldman Sachs
60
Goldman Sachs
New York
$42K -$42.3K -15,084 -50%
CPIG
61
Chicago Partners Investment Group
Illinois
$33K
CSS
62
Cubist Systematic Strategies
Connecticut
$33K +$33K +11,742 New
Acadian Asset Management
63
Acadian Asset Management
Massachusetts
$29K +$29.3K +10,446 New
SI
64
Stephens Inc
Arkansas
$28K +$28.1K +10,000 New
PCM
65
Prelude Capital Management
New York
$22K +$22.5K +8,000 New
AG
66
Advisor Group
Arizona
$20K -$1.15K -410 -6%
Bank of America
67
Bank of America
North Carolina
$20K +$19.5K +6,934 +4,849%
Walleye Trading
68
Walleye Trading
New York
$20K +$19.6K +7,000 New
LTFS
69
Ladenburg Thalmann Financial Services
Florida
$19K
FCMT
70
Founders Capital Management (Texas)
Texas
$17K
Deutsche Bank
71
Deutsche Bank
Germany
$16K -$2.25K -803 -13%
IA
72
IFP Advisors
Florida
$9K
Group One Trading
73
Group One Trading
Illinois
$8K -$15.7K -5,600 -66%
EARNEST Partners
74
EARNEST Partners
Georgia
$8K
Simplex Trading
75
Simplex Trading
Illinois
$5K -$13.6K -4,827 -73%

BDSI Hedge Fund Activity: Q3 2018 in Review

83 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q3 2018, worth a combined $112M — up 40% from $79.9M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new BDSI positions and 7 closed out — a net gain of 15 holders — while 27 added to existing stakes and 15 trimmed.

The largest buyer was Armistice Capital, adding an estimated $8.9M. The largest seller was Royce & Associates, cutting an estimated $4.82M.

  • 83 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q3 2018, up from 68 in Q2 2018.
  • Funds reported $112M of BioDelivery Sciences International, Inc. stock for Q3 2018, up 40% quarter-over-quarter.
  • 22 funds opened new BioDelivery Sciences International, Inc. positions in Q3 2018 and 7 closed out, a net change of +15 holders.
  • The largest BioDelivery Sciences International, Inc. buyer in Q3 2018 was Armistice Capital, an estimated $8.9M added.
  • The largest BioDelivery Sciences International, Inc. seller in Q3 2018 was Royce & Associates, an estimated $4.82M sold.

Based on aggregated 13F filings for Q3 2018.